
MDH1-IN-1
CAS No. 2143463-31-2
MDH1-IN-1( —— )
Catalog No. M35534 CAS No. 2143463-31-2
MDH1-IN-1 (5i) is a potent MDH1 inhibitor with an IC50 of 6.79 μM for MDH1 and >40 μM for MDH2.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMDH1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionMDH1-IN-1 (5i) is a potent MDH1 inhibitor with an IC50 of 6.79 μM for MDH1 and >40 μM for MDH2.
-
DescriptionMDH1-IN-1 (Compound 5i) is a potent inhibitor of MDH1 with an IC50 of 6.79 μM. MDH1-IN-1 has the potential for the research of cancer diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2143463-31-2
-
Formula Weight355.43
-
Molecular FormulaC21H25NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (281.35 mM; Ultrasonic )
-
SMILESCCCCCc1ccc(OCC(=O)Nc2cccc(c2)C(=O)OC)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Naik R, et al. Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism. J Med Chem. 2017;60(20):8631-8646.?
molnova catalog



related products
-
PAMBA
4-(Aminomethyl)benzoic acid is an unnatural amino acid derivative, is an antifibrinolytic.
-
Tegadifur
Tegadifur (40497S) is an orally available antitumor compound with antimetabolic effects, often used with uracil and in the treatment of rectal adenocarcinoma.
-
Lumiliximab
Lumiliximab (IDEC-152) is a primate-ized chimeric antibody targeting CD23 rhesus monkey/human chimeric antibody with inhibitory effects on IgE antibody production for the study of allergic diseases.